Journal article
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder
Abstract
Borderline personality disorder (BPD) has high rates of comorbidity with mood disorders, including treatment-resistant depression (TRD). Comorbidity of BPD with depression is associated with poorer response to antidepressants. Intravenous ketamine is a novel treatment for TRD that has not been specifically evaluated in patients with comorbid BPD. In this retrospective analysis of data collected from participants who received care at the …
Authors
Danayan K; Chisamore N; Rodrigues NB; Vincenzo JDD; Meshkat S; Doyle Z; Mansur R; Phan L; Fancy F; Chau E
Journal
Psychiatry Research, Vol. 323, ,
Publisher
Elsevier
Publication Date
May 2023
DOI
10.1016/j.psychres.2023.115133
ISSN
0165-1781